Please assess the completion status of the following clinical trial:

Trial Title: Safety and Preliminary Efficacy of Combination Therapy for the Treatment of Acne Vulgaris

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: NONE
- Phase: None
- Number of Arms: 3.0

Eligibility Criteria:
Inclusion Criteria:~* Have mild to moderate facial acne~* Have Fitzpatrick skin type II-V~* Be able to understand written and/or spoken English~* Be able to provide written informed consent.~Exclusion Criteria:~* Have been treated with oral retinoids in the past 6 months~* Have been treated with oral antibiotic within the last 30 days~* Have received topical acne treatment (i.e. retinoids, antibiotics and anti-inﬂammatory agents or chemical peeling) within the last 30 days~* Pregnant or lactating~* Have history of photo-sensitive dermatitis~* Have previously received light therapy~* Taking oral contraceptive pills (OCP)~* Have pacemaker

- Gender: ALL
- Minimum Age: 18 Years
- Maximum Age: 30 Years
- Healthy Volunteers: f

Study Arms:
- BLP arm (Blue Light Phototherapy) (Type: ACTIVE_COMPARATOR): In this arm participants will receive 5 BLP sessions at 1 week intervals. The duration of each session will be approximately 20 minutes. At each session, the affected areas of the participant's face will be exposed to a light source using blue light phototherapy machine between 15 to 20 minutes.
- MCT arm (Microcurrent Therapy) (Type: ACTIVE_COMPARATOR): In this arm participants will receive 5 MCT sessions 1 week intervals using MCT machine. The duration of each session will be approximately 45 minutes. The investigators will place one electrode in one of the regional areas of the lymph nodes or affected area (i.e. the forehead) and move the second electrode systematically from the affected area towards the stationary electrode. Once the entire affected area has been covered, the investigators will move the first electrode to another regional area of the lymph nodes or affected area and the process will be repeated. This will continue until all of the affected areas have been treated.
- Combination of BLP and Microcurrent (Type: ACTIVE_COMPARATOR): In this arm participants will receive 5 BLP and 5 MCT sessions at 1 week intervals. At each session, participants will receive MCT portion as described in above followed by BLP portion as described above. These visits will last approximately 65 minutes.

Based on this trial design, predict the completion outcome and termination type (if applicable).